Summary
Mānuka honey is sold at nearly $10,000 per jin, graded by UMF value (e.g. UMF5+, 10+, 15+, 20+), with higher UMF indicating stronger antibacterial activity. Chinese food industry analyst Zhu Danpeng believes the overall efficacy is exaggerated and lacks clinical data. Beekeeper He Xin points out that all pure honey has similar benefits, and the high price is a marketing strategy.
Lawyer Zhang Pengbo states that false advertising may violate the Advertising Law and incur fines. The article also notes that the national honey standard lacks quality and authenticity testing, leading to counterfeit issues.
Commentary
The high premium of Mānuka honey relies on UMF grading and efficacy claims, but expert doubts and legal risks remind New Zealand exporters: in the Chinese market, product claims must be scientifically supported and compliant, or they risk regulatory penalties. Meanwhile, the gap in China's national honey standard for quality and authenticity testing offers a differentiation opportunity for certified high-quality honey. Small and medium-sized enterprises can build trust through third-party testing and traceability systems, avoid exaggerating benefits, and instead focus on origin ecology and traditional processes.
Going forward, consumer demand for natural products remains strong, but brand credibility is the core of long-term competitiveness.
Keywords: Mānuka honey, UMF value, exaggerated efficacy, marketing strategy, false advertising, national standard, consumer trust, China-New Zealand trade
Source: Sohu
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
